MANDATO, Claudia
 Distribuzione geografica
Continente #
AS - Asia 4.536
NA - Nord America 3.493
EU - Europa 1.208
SA - Sud America 439
AF - Africa 34
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 1
Totale 9.716
Nazione #
US - Stati Uniti d'America 3.422
HK - Hong Kong 2.850
SG - Singapore 855
BR - Brasile 366
CN - Cina 359
IT - Italia 352
RU - Federazione Russa 238
VN - Vietnam 201
UA - Ucraina 161
IE - Irlanda 105
DE - Germania 103
TR - Turchia 53
KR - Corea 52
FI - Finlandia 44
SE - Svezia 44
IL - Israele 41
GB - Regno Unito 40
IN - India 37
MX - Messico 31
CA - Canada 30
AT - Austria 29
AR - Argentina 25
NL - Olanda 23
BD - Bangladesh 18
PL - Polonia 17
ID - Indonesia 14
IQ - Iraq 14
EC - Ecuador 13
ES - Italia 11
JP - Giappone 11
CZ - Repubblica Ceca 10
ZA - Sudafrica 10
FR - Francia 9
CO - Colombia 8
PE - Perù 8
VE - Venezuela 8
EU - Europa 5
PY - Paraguay 5
UZ - Uzbekistan 5
BY - Bielorussia 4
EG - Egitto 4
KE - Kenya 4
PK - Pakistan 4
TN - Tunisia 4
CR - Costa Rica 3
DO - Repubblica Dominicana 3
LT - Lituania 3
SV - El Salvador 3
AE - Emirati Arabi Uniti 2
BE - Belgio 2
CL - Cile 2
DZ - Algeria 2
ET - Etiopia 2
JO - Giordania 2
LB - Libano 2
MA - Marocco 2
MD - Moldavia 2
OM - Oman 2
RO - Romania 2
SA - Arabia Saudita 2
UY - Uruguay 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AU - Australia 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
CI - Costa d'Avorio 1
DK - Danimarca 1
GE - Georgia 1
GF - Guiana Francese 1
GR - Grecia 1
HR - Croazia 1
IR - Iran 1
IS - Islanda 1
JM - Giamaica 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LU - Lussemburgo 1
ME - Montenegro 1
ML - Mali 1
MW - Malawi 1
PH - Filippine 1
PS - Palestinian Territory 1
RS - Serbia 1
SN - Senegal 1
TL - Timor Orientale 1
UG - Uganda 1
YT - Mayotte 1
Totale 9.716
Città #
Hong Kong 2.844
Ann Arbor 567
Singapore 441
Dallas 325
Woodbridge 317
Chandler 288
Princeton 222
Ashburn 219
Jacksonville 191
Wilmington 167
Houston 148
Dublin 97
Naples 90
Dong Ket 76
Beijing 75
Moscow 50
Los Angeles 49
Ho Chi Minh City 44
Nanjing 41
Izmir 40
Dearborn 39
New York 39
Andover 35
Boardman 35
Pellezzano 33
The Dalles 31
Salerno 30
São Paulo 28
Washington 26
Mestre 23
Brooklyn 22
Hanoi 21
Vienna 20
Munich 19
Santa Clara 19
Nuremberg 18
Denver 17
Amsterdam 16
Düsseldorf 16
Shenyang 16
Stockholm 16
Atlanta 15
Chicago 15
Seattle 15
Warsaw 15
San Francisco 14
Council Bluffs 13
Norwalk 13
Pune 13
Fairfield 12
Montreal 12
Chennai 11
Rio de Janeiro 11
Rome 11
Seoul 11
West Jordan 11
Brno 10
Hebei 10
Jiaxing 10
London 10
Tianjin 10
Tokyo 10
Ankara 9
Mexico City 9
Columbus 8
Johannesburg 8
Nanchang 8
San Diego 8
Curitiba 7
Haiphong 7
Phoenix 7
Poplar 7
Baghdad 6
Biên Hòa 6
Boston 6
Lappeenranta 6
Arba 5
Brasília 5
Caracas 5
Charlotte 5
Eboli 5
Frankfurt am Main 5
Goiânia 5
Guayaquil 5
Helsinki 5
Manchester 5
Milan 5
Nola 5
Orem 5
Quito 5
Redwood City 5
Ribeirão Preto 5
San Jose 5
Shanghai 5
Tashkent 5
Turku 5
Belo Horizonte 4
Buenos Aires 4
Cairo 4
Calgary 4
Totale 7.280
Nome #
Hepatitis B virus and the paediatric liver: waiting for news on the horizon 726
Liver and Pancreatic Involvement in Children with Multisystem Inflammatory Syndrome Related to SARS-CoV-2: A Monocentric Study 347
Pediatric liver diseases and ocular changes: What hepatologists and ophthalmologists should know and share with each other 342
Multiple gut-liver axis abnormalities in children with obesity with and without hepatic involvement 318
Pediatric parenteral nutrition-associated liver disease and cholestasis: Novel advances in pathomechanisms-based prevention and treatment. 285
Thyroid dysfunction and its role as a risk factor for non-alcoholic fatty liver disease: What's new 241
A systematic review of pediatrics NAFLD therapy: year 2012 219
Metabolomic salivary signature of pediatric obesity related liver disease and metabolic syndrome 207
Refractory primary sclerosing cholangitis becoming responsive after sulphasalazine treatment of an underlying silent colitis 192
Humanization interventions in general pediatric wards: a systematic review 177
Management of adults with paediatric-onset chronic liver disease: Strategic issues for transition care 168
A NEW POSSIBLE THERAPEUTIC STRATEGY IN OBESITYRELATED LIVER DISEASE: PRELIMINARY DATA WITH LACTOBACILLUS RHAMNOSUS STRAIN GG 159
Hepatic Presentation of Late-Onset Multiple Acyl-CoA Dehydrogenase Deficiency (MADD): Case Report and Systematic Review 155
Atypical celiac disease presenting as obesity-related liver dysfunction. 143
Association of Very Rare NOTCH2 Variants with Clinical Features of Alagille Syndrome 142
Antioxidant vitamin E for the treatment of obesità related liver dysfunction in children with poor compliance to hypocaloric diets 139
Autoantibodies against CYP-2C19: A Novel Serum Marker in Pediatric De Novo Autoimmune Hepatitis? 132
Probiotics in the treatment of Non Alcoholic Fatty Liver Disease: Further evidence in obese children 124
Textbook of liver transplatation. Transition to Adult Care: Adolescents Care 123
LACTOBACILLUS RHAMNOSUS STRAIN GG DESERVES CONSIDERATION AS A THERAPEUTIC TOOL IN OBESITY-RELATED LIVER DISEASE 123
Autoimmune manifestations in pediatric liver transplantation recipients 122
Autoimmune manifestations in children transplanted for non-autoimmune liver diseases 119
Metabolic, hormonal, oxidative, and inflammatory factors in pediatricobesity-related liver disease 116
Analgesic effects of breast- and formula feeding during routine childhood immunizations up to 1 year of age 109
Probiotics: a possible role in treatment of adult and pediatric non alcoholic fatty liver disease 108
Cytochrome 2C19: a New Hepatic Target of Immune Reactions After Orthopic Liver Transplantation. 106
More on current evidences on probiotics as a novel treatment for non-alcoholic Fatty liver disease 105
Cryptogenic liver disease in four children: a novel congenital disorder of glycosylation 102
Gut-liver axis and probiotics: Their role in non-alcoholic fatty liver disease 101
Pediatric non-alcoholic fatty liver disease: Recent solutions, unresolved issues, and future research directions 101
Insulin sensitivity and iron metabolism in pediatric obesity related liver disease. 100
Frequent persistence of hepatic abnormalities in children with hereditary fructose intolerance (HFI) is not correlated to specific gene mutations. 100
Chronic liver disease in two children exposed to moderately high levels of copper in drinking water. 100
Novel congenital disorders of glycosylation may underlie cryptogenic liver disease in children. 99
A ZFYVE19 gene mutation associated with neonatal cholestasis and cilia dysfunction: case report with a novel pathogenic variant 98
Interplay between metabolic, oxidative, inflammatory and hormonal factors in pediatric obesity related liver disease. 97
Congenital defects of glycosylation may underlie cryptogenic hepatopathy in asymptomatic children 97
Chronic ingestion of moderately high copper may cause cryptogenic mild liver disease 96
Per-rectal portal scintigraphy is complementary to ultrasonography and endoscopy in the assessment of portal hypertension in children with chronic cholestasis 95
Oral vitamin E has beneficial effects on liver disease of obese children unable to loose weight 94
Non-cirrhotic chronic liver disease in three italian children exposed to moderately high copper intakes 92
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) antigen detection in the Emergency Department: data from a pediatric cohort during the fourth COVID-19 wave in Italy 86
Rhabdomyolysis and coeliac disease: A causal or casual association? A case report and review of literature 85
Humanization of pediatric care in the world: focus and review of existing models and measurement tools. 85
Human Parvovirus B19 Infection in liver transplanted children with chronic hematologic disorders. 84
More on vitamin E therapy 82
Vitamin E treatment in pediatric obesity-related liver disease: a randomized study. 79
Pediatric vs. adult NAFLD to MAFLD transition: a welcome but tangled path 76
Global multi-stakeholder endorsement of the MAFLD definition 69
Oxidative Stress in Non-alcoholic Fatty Liver Disease. An Updated Mini Review 68
Outbreak of paediatric myocarditis associated with parvovirus B19 infection in Italy, January to October 2024 65
Three unreported cases of TMEM199-CDG, a rare genetic liver disease with abnormal glycosylation 64
Genotypes and different clinical variants between children and adults in progressive familial intrahepatic cholestasis: a state-of-the-art review 58
Case report: Reversible Fanconi syndrome due to vitamin D deficiency in a patient with epilepsy harbouring a pathogenic variant in the SLC34A1 gene 58
Nutrition and Liver Disease 54
Liver Involvement in Congenital Disorders of Glycosylation: A Systematic Review 54
Pediatric Fatty Liver and Obesity: Not Always Justa Matter of Non-Alcoholic Fatty Liver Disease 53
Bassa statura non sindromica e ritardo puberale: non solo ritardo costituzionale di crescita e pubertà 52
Multisystem inflammatory syndrome in children. An emerging clinical challenge for pediatric surgeons in the COVID 19 era 51
Drug dosing in children with obesity: a narrative updated review 50
Ittero e feci ipocoliche: allarme atresia delle vie biliari 50
Multiple Sclerosis-Related Dietary and Nutritional Issues: An Updated Scoping Review with a Focus on Pediatrics 48
ALAGILLE SYNDROME: IS IT ALWAYS CHOLESTASIS? 48
Case report: Unusual and extremely severe lipoprotein X-mediated hypercholesterolemia in extrahepatic pediatric cholestasis 47
Monkeypox Infection 2022: An Updated Narrative Review Focusing on the Neonatal and Pediatric Population 47
Diagnostic Approach to Acute Liver Failure in Children: A Position Paper by the SIGENP Liver Disease Working Group 47
Crohn-Like Colitis in a Young Boy with Hirschsprung Disease 46
Real-word experience with Odevixibat in children with Progressive Familial Intrahepatic Cholestasis 45
Clinical heterogeneity of Kabuki syndrome in a cohort of Italian patients and review of the literature 45
Laryngeal Mask for Minimally-Invasive Surfactant Administration: A Narrative Review 44
The gut-liver axis as a target of liver disease management 44
Genetics, epigenetics and transgenerational transmission of obesity in children 42
Systemic Cat-Scratch Disease: a "Troublesome" Diagnosis 42
Frailty in children with chronic liver disease: Growing evidence for an underexplored topic 41
Cholestatic jaundice in infancy: Struggling with many old and new phenotypes 41
Consumptive Hypothyroidism due to Hepatic Hemangiomas: A Case Series and Review of the Literature 39
Malnutrition in pediatric chronic cholestatic disease: An up-to-date overview 39
A persistent fever associated with elevated inflammatory indices and ultrasound lesions of liver and spleen 39
Letter to the editor in response to distinguishing autoimmune hepatitis from steatohepatitis in adolescents with obesity and positive screening alanine aminotransferase 37
Reasons why treatment of metabolic dysfunction‐associated steatotic liver disease may benefit from targeting the gut–liver axis as well 37
Acute hepatitis of unknown origin in children: Should we move the discussion from a purely infectious origin also to other plausible causes? 37
Pulmonary lipid modulation: A possible therapeutic target for SARS-CoV-2 infection 36
Primary and Secondary Prophylaxis of Gastrointestinal Bleeding in Children with Portal Hypertension: A Multicenter National Study by SIGENP 36
Vitamin D Levels in the Pre- and Post-COVID-19 Pandemic Periods and Related Confinement at Pediatric Age 35
Diagnostic approach to neonatal and infantile cholestasis: A position paper by the SIGENP liver disease working group 35
Letter to the Editor in response to: “ZFYVE19 gene mutation: A novel variant of progressive familial intrahepatic cholestasis” 34
An odd septic arthritis of the hip 34
An almost accidentally diagnosis 32
Juvenile erythrocytosis in children after liver transplantation: prevalence, risk factors and outcome 31
The complexity of diagnosing a drug reaction syndrome in the child|La complessità della diagnosi di una sindrome da reazione a farmaco nel bambino 31
Case Report: Add-on treatment with odevixibat in a new subtype of progressive familial intrahepatic cholestasis broadens the therapeutic horizon of genetic cholestasis 30
Perceptions and Expectations of Youth Regarding the Respect for Their Rights in the Hospital 30
Bronchiolitis: Compliance with guidelines 30
Emerging, re‐emerging and/or atypically behaving infectious diseases 30
Celiac Disease on the Bed-Side: Embedding Case Finding and Screening in Hospitalized Children 28
Isolated aspartate aminotransferase elevation: Is it liver disease or what else? 28
Evaluation of non organ specific autoantibodies in children transplanted for non-autoimmune liver diseases 27
Thrombotic Features as the Primary Cause of SARS-CoV-2 Related Acute Abdomen in Children 26
The C677T mutation of the 5,1O-methylenetetrahydrofolate reductase gene is a moderate risk factor for spina bifida in Italy 25
Nutritional therapy in liver transplantation 25
Totale 9.380
Categoria #
all - tutte 35.582
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.582


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021234 0 0 0 0 0 9 33 4 50 7 44 87
2021/2022360 5 0 0 3 6 2 1 10 52 39 51 191
2022/2023721 70 51 54 83 78 158 1 56 120 4 35 11
2023/2024533 29 48 43 25 32 89 41 24 14 43 24 121
2024/20251.193 21 22 19 54 42 190 185 100 184 101 175 100
2025/20264.939 375 1.840 1.514 322 658 230 0 0 0 0 0 0
Totale 9.910